Re: Last hour.....
|
4
|
Resverlogix Corp.
|
Jun 01, 2019 01:51AM
|
CKD Reata / Market Cap
|
4
|
Resverlogix Corp.
|
May 03, 2019 09:36AM
|
Re: Reata Nasdaq Symbol RETA
|
4
|
Resverlogix Corp.
|
May 03, 2019 10:07AM
|
Re: 3 point MACE in Phase 3 should be 10% percent lower than 4 point MACE in Phase 2's
|
4
|
Resverlogix Corp.
|
Nov 06, 2018 10:50AM
|
Endocyte Valuation
|
4
|
Zenith Epigenetics
|
Oct 18, 2018 02:14PM
|
Re: Amarin / Mineral Oil
|
4
|
Resverlogix Corp.
|
Nov 10, 2018 03:57PM
|
Re: Bio Europe presentation happening now
|
4
|
Resverlogix Corp.
|
Nov 06, 2018 01:21PM
|
Re: MACE event rate
|
4
|
Resverlogix Corp.
|
Nov 04, 2018 08:24AM
|
R & D
|
4
|
Resverlogix Corp.
|
Jul 30, 2019 11:12AM
|
Re: MACE event rate
|
4
|
Resverlogix Corp.
|
Nov 04, 2018 10:58AM
|
Re: Complement and AD
|
3
|
Resverlogix Corp.
|
Nov 11, 2018 03:09PM
|
Re: Crestor / Lipitor
|
3
|
Resverlogix Corp.
|
May 02, 2019 12:12PM
|
Re: HDL Functionality
|
3
|
Resverlogix Corp.
|
May 08, 2019 05:32PM
|
Re: HDL Functionality
|
3
|
Resverlogix Corp.
|
May 06, 2019 10:49AM
|
AMRN / Adcom
|
3
|
Resverlogix Corp.
|
Aug 10, 2019 09:57AM
|
Re: Question about Phase 2
|
3
|
Resverlogix Corp.
|
Mar 12, 2019 09:50AM
|
Re: Shawn lu RSU and option cancelled
|
3
|
Resverlogix Corp.
|
Apr 07, 2020 10:44AM
|
Re: AHA 2018
|
3
|
Resverlogix Corp.
|
Nov 12, 2018 11:49AM
|
Publication / Resverlogix An Author
|
3
|
Resverlogix Corp.
|
Aug 20, 2019 10:46AM
|
Re: HDL Functionality
|
3
|
Resverlogix Corp.
|
May 09, 2019 07:09PM
|